COVID-19 vaccine information click here


On this page we’ll keep you up to date with developments in the department and with news from the wider world of rheumatology and links to the relevant websites.

We plan to update this as often as possible so do keep checking back to keep up to date!

Local news

There are now 4 rheumatology clinics (and 4 nurse practitioner clinics) per week running at the Northern General Hospital in our own dedicated out patient area within the Metabolic Bone Unit. We have introduced this service to provide greater out patient provision at the Northern and to provide easier access to inpatient referrals four days a week. Dr Tim Tait took up his post as Consultant Rheumatologist in Sept 2010 and is based at NGH 3 days a week with Dr Simon Till being there 1 day a week. Further expansion of services at the NGH is planned later in 2011.

Waiting times within the department continue to fall with all patients being seen and treated within the 18 week limit. All general rheumatology new patient clinics are now available on Choose and Book through your GP’s

Early arthritis clinic up and running
We have introduced a clinic for people with the early stages of inflammatory arthritis which is now running twice a month. The service is shortly to improve still further with the introduction of ultrasound assessment of inflamed joints being done within the same clinic and at the same visit. Using this we hope to improve the diagnosis and thus treatment of this important group of patients.

National news

NICE re-iterates guidance on osteoporosis
The National Institute for Health and Clinical Excellence (NICE) has re-examined its advice regarding the treatment and prevention of primary and secondary osteoporosis following a court decision. The advice remains unchanged and you can read their full guidance here (link to

NICE has also in the past year examined several issues to do with rheumatology. You may wish to look at their guidance on Psoriatic arthritis and anti-TNF drugs ( ), rheumatoid arthritis and tocilizumab ( ), or on treatment of rheumatoid arthritis after failure of TNF therapy ( ). NICE has also this past year looked at Certolizumab p[egol in rheumatoid and at several orthopaedic operations that patients with arthritis may be offered. You can look at their guidance on these operations by visiting their website ( )


< back

Rate this page: